Thomas C Thottathil
BSV to set up vaccine manufacturing facility in Genome Valley
By Thomas C Thottathil - April 13, 2022
The total investment is in the region of Rs 200 crore
IDMA set for its Diamond Jubilee celebrations on April 14-15th
By Thomas C Thottathil - April 13, 2022
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
Cadila Pharma launches world’s first three-dose rabies vaccine
By Thomas C Thottathil - April 08, 2022
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Molbio Diagnostics’ Truenat platform deployed to diagonise TB in India
By Thomas C Thottathil - March 24, 2022
This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system
Industry upbeat on biopharma sector
By Thomas C Thottathil - March 08, 2022
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Adopt digitisation & automation for business sustainability and quality excellence : CEOs
By Thomas C Thottathil - March 01, 2022
Pankaj Patel, Chairman, Zydus Lifesciences; Umang Vohra, CEO, Cipla; G V Prasad, Co-Chairman, Dr Reddy's; Nilesh Gupta, MD, Lupin and Dilip Shanghvi, MD, Sun Pharmaceuticals sharing their vision to outline the roadmap for the industry.
Industry seeks favourable policy for India to move up the pharma value chain globally
By Thomas C Thottathil - February 27, 2022
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Risk appetite key to innovation in pharma and biopharma
By Thomas C Thottathil - February 25, 2022
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
Telangana draws Rs 6,400 crore investment in pharma sector in 2021 : KT Rama Rao
By Thomas C Thottathil - February 24, 2022
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary
By Thomas C Thottathil - February 24, 2022
Collaboration in the industry needs to be institutionalised to drive the growth.
We achieved 40% revenue growth in 2021 : Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals
By Thomas C Thottathil - January 11, 2022
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Alarming rise in diabetes amongst children and adolescents in India
By Thomas C Thottathil - November 14, 2021
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
